BIOTESS CAPRAMAX

What this means for you

Registered since 15 Sept 2026. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

99391333

Registration number

8444715

Mark type

Stylized text

Filed

13 Sept 2025

Published for opposition

27 Jan 2026

Registered

15 Sept 2026

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical feature in the nature of proprietary nutrient-delivery agents that enhance nutrient absorption and bioavailability, namely, a feature in the nature of nutrient delivery agents in the form of powders that provide controlled release of active ingredients for a wide variety of dietary supplements, nutritional supplements, and pharmaceutical preparations, sold as an integral component of dietary supplements, nutritional supplements, and pharmaceutical preparations for the treatment of cardiovascular, neurological, cognitive, digestive, inflammatory, anxiety, weight management, and metabolic health conditions.

Owner

• Tesseract Medical Research, LLC, Laguna Hills, CA, US
• Tesseract Medical Research, LLC, Laguna Hills, CA, US
• Tesseract Medical Research, LLC, Laguna Hills, CA, US

Prosecution history

• 15 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
• 26 Aug 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
• 26 Aug 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
• 23 Jun 2026 — STATEMENT OF USE PROCESSING COMPLETE
• 25 Mar 2026 — USE AMENDMENT FILED
• 25 Mar 2026 — TEAS STATEMENT OF USE RECEIVED
• 24 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 27 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 27 Jan 2026 — PUBLISHED FOR OPPOSITION
• 21 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 05 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 31 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 31 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 31 Dec 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
• 29 Dec 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED